Neoadjuvant Osimertinib with/without Chemotherapy versus Chemotherapy in Patients with EGFR-mutated resectable NSCLC: NeoADAURA-MedSci.cn - 梅斯（MedSci）

Neoadjuvant Osimertinib with/without Chemotherapy versus Chemotherapy in Patients with EGFR-mutated resectable NSCLC: NeoADAURA

Griesinger, F; Tsuboi, M; Weder, W; Escriu, C; Blakely, C; He, J; Dacic, S; Yatabe, Y; Zeng, L; Walding, A; Chaft, J

PNEUMOLOGIE, 2021; 75 (): S6

科室
- - 订阅+
  - 更多科室
工具
服务